ERNA, ERNAW · CIK 0000748592 · operating
Ernexa Therapeutics Inc. (ERNA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $8 million, Ernexa Therapeutics Inc. is a micro-cap company. The stock currently trades at $0.29, up 1.72% today, with a 52-week range of $0.27–$4.50. The company trades at a trailing P/E of 0.0x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-3.26 | $-3.26 | +20.1% | |
| 2023 | $-4.08 | $-4.08 | +49.4% | |
| 2022 | $-8.06 | $-8.06 | -185.8% | |
| 2021 | $-2.82 | $-2.82 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-12 | 0001493152-25-010051 | SEC ↗ |
| 2023-12-31 | 2024-03-14 | 0001140361-24-013254 | SEC ↗ |
| 2022-12-31 | 2023-03-20 | 0001140361-23-012418 | SEC ↗ |
| 2021-12-31 | 2022-04-15 | 0001140361-22-014764 | SEC ↗ |
| 2020-12-31 | 2021-03-11 | 0001493152-21-005827 | SEC ↗ |
| 2019-12-31 | 2020-03-19 | 0001493152-20-004343 | SEC ↗ |
| 2018-12-31 | 2019-03-22 | 0001493152-19-003770 | SEC ↗ |
| 2017-12-31 | 2018-03-09 | 0001493152-18-003164 | SEC ↗ |
| 2016-12-31 | 2017-03-09 | 0001493152-17-002280 | SEC ↗ |
| 2015-12-31 | 2016-03-15 | 0001493152-16-008049 | SEC ↗ |
| 2014-12-31 | 2015-03-27 | 0001019687-15-001115 | SEC ↗ |
| 2013-12-31 | 2014-03-31 | 0001019687-14-001135 | SEC ↗ |
| 2012-12-31 | 2013-03-29 | 0001019687-13-001065 | SEC ↗ |
| 2011-12-31 | 2012-03-30 | 0001019687-12-001146 | SEC ↗ |
| 2010-12-31 | 2011-03-25 | 0001019687-11-000960 | SEC ↗ |
| 2009-12-31 | 2010-03-31 | 0001019687-10-001222 | SEC ↗ |